OverviewSuggest Edit

PetMed Express markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Company's products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. PetMed also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties.

TypePublic
Founded1996
HQPompano Beach, US
Website1800petmeds.com
Employee Ratings2.7

Latest Updates

Employees (est.) (Mar 2019)199(+7%)
Revenue (FY, 2019)$283.4 M(+4%)
Share Price (Jan 2020)$25.6 (-6%)

PetMed Express Office Locations

PetMed Express has offices in Pompano Beach and Delray Beach
Pompano Beach, US (HQ)
1441 SW 29th Ave
Delray Beach, US
420 S Congress Ave #100
Delray Beach, US
420 S Congress Ave #100Delray
Show all (3)

PetMed Express Financials and Metrics

PetMed Express Revenue

Embed Graph
View revenue for all periods
PetMed Express's revenue was reported to be $283.42 m in FY, 2019
USD

Revenue (Q2, 2020)

69.9m

Gross profit (Q2, 2020)

20.0m

Gross profit margin (Q2, 2020), %

28.6%

Net income (Q2, 2020)

6.7m

EBIT (Q2, 2020)

8.4m

Market capitalization (21-Jan-2020)

550.0m

Closing stock price (21-Jan-2020)

25.6

Cash (30-Sept-2019)

94.9m
PetMed Express's current market capitalization is $550 m.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

238.3m227.8m233.4m229.4m234.7m249.2m273.8m283.4m

Revenue growth, %

(2%)2%6%

Cost of goods sold

158.1m150.7m155.8m153.1m158.4m169.9m176.0m188.1m

Gross profit

80.2m77.1m77.6m76.3m76.3m79.3m97.8m95.3m
Quarterly
USDQ2, 2012Q1, 2013Q2, 2013Q3, 2013Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

58.2m69.0m58.1m49.6m60.5m50.1m72.5m57.6m49.3m71.6m56.7m50.9m72.5m60.8m52.9m79.7m66.7m60.1m87.4m71.4m60.1m80.0m69.9m

Cost of goods sold

38.3m46.7m38.8m32.4m41.2m33.2m48.8m39.1m32.2m48.7m37.8m34.2m50.0m42.7m36.2m52.2m43.2m38.2m57.4m46.1m40.7m58.1m49.9m

Gross profit

19.9m22.3m19.4m17.2m19.3m16.9m23.8m18.5m17.1m23.0m18.9m16.8m22.5m18.1m16.6m27.5m23.5m21.9m30.0m25.3m19.4m21.9m20.0m

Gross profit Margin, %

34%32%33%35%32%34%33%32%35%32%33%33%31%30%31%34%35%37%34%35%32%27%29%
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

46.8m18.2m18.3m35.6m37.6m58.7m77.9m100.5m

Accounts Receivable

1.6m1.4m1.8m1.9m1.7m2.3m2.5m

Prepaid Expenses

1.2m2.5m1.8m1.4m2.4m882.0k1.4m

Inventories

26.2m31.6m35.7m25.1m25.6m23.3m21.4m
Quarterly
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

16.7m17.2m18.0m17.5m20.6m23.8m37.3m37.7m

Depreciation and Amortization

1.4m1.1m867.0k660.0k770.0k1.4m2.1m2.2m

Accounts Payable

297.0k(165.0k)(686.0k)(616.0k)(149.0k)10.2m53.0k1.0m

Cash From Operating Activities

20.4m13.3m13.5m32.0m21.1m47.2m37.4m45.1m
Quarterly
USDQ2, 2012Q1, 2013Q2, 2013Q3, 2013Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

8.8m4.0m8.0m12.6m4.2m13.4m5.0m7.7m12.5m5.8m10.3m15.1m6.6m4.9m16.3m9.3m18.0m27.1m12.6m23.3m31.1m5.3m12.0m

Depreciation and Amortization

687.0k328.0k577.0k831.0k230.0k697.0k163.0k322.0k487.0k191.0k377.0k544.0k194.0k204.0k855.0k531.0k1.1m1.6m556.0k1.1m1.7m568.0k1.1m

Accounts Payable

86.0k633.0k337.0k(645.0k)(2.4m)2.8m(521.0k)(1.9m)4.8m2.1m212.0k2.3m6.1m387.0k984.0k(4.8m)(2.8m)5.9m(996.0k)5.0m(586.0k)(1.1m)

Cash From Operating Activities

16.2m13.8m15.7m21.8m17.7m14.3m23.6m29.5m10.8m14.0m22.6m13.1m31.6m13.9m18.3m35.1m22.0m20.4m32.0m36.0k17.3m
USDY, 2019

Financial Leverage

1.2 x
Show all financial metrics

PetMed Express Operating Metrics

PetMed Express's Customers was reported to be 514 k in FY, 2017.
FY, 2014Q1, 2015Q2, 2015Q3, 2015FY, 2015Q1, 2016Q2, 2016Q3, 2016FY, 2016Q1, 2017Q2, 2017Q3, 2017FY, 2017Q1, 2018Q2, 2018

Average Spending per Transaction

$75 $82 $75 $76 $77 $82 $80 $78 $81 $82 $82 $81 $83 $87 $85

Customers

597 k529 k489 k514 k

Stock Keeping Units

3 k3 k3 k3 k

Visitors

27 m30 m33 m32 m
Show all operating metrics

PetMed Express Online and Social Media Presence

Embed Graph

PetMed Express News and Updates

PetMed Express d/b/a 1-800-PetMeds Announces Its Third Fiscal Quarter Financial Results and Its Quarterly Dividend of $0.27 Per Share

Gross Margins Improved Sequentially from 28.6% to 29.5%Net Income Margins Increased 180 Basis Points SequentiallyAverage Order Size increased from $84 to $85

Thinking about buying stock in Canopy Growth Corp, Micron Technology, Petmed Express, Sorrento Therapeutics, or Target?

NEW YORK, Jan. 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CGC, MU, PETS, SRNE, and TGT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

PetMed Express d/b/a 1-800-PetMeds Announces Its Second Fiscal Quarter Financial Results and Its Quarterly Dividend of $0.27 per Share

Quarterly Reorder Sales Increased 1.4%Gross Margins Improved Sequentially from 27.3% to 28.6%Operating Margins Increased 430 Basis Points Sequentially

PetMed Express shares fall 12% after earnings and sales miss

PetMed Express Inc. shares sank 12.5% in Monday premarket trading after the pet pharmacy company reported fiscal first quarter earnings and sales that missed consensus. Net income totaled $5.3 million, or 26 cents per share, down from $12.6 million, or 62 cents per share, last year. Sales of $80.0 …

PetMed Express D/B/A 1-800-PetMeds Announces Its First Fiscal Quarter Financial Results and Its Quarterly Dividend of $0.27 Per Share

DELRAY BEACH, Fla., July 22, 2019 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended June 30, 2019.  Net sales for the quarter ended June 30, 2019 were $80.0 million, compared to $87.4 million for the quarter ended June 30, 2018, a d…

PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Its Fourth Quarter and Fiscal Year End Financial Results and Declares Its $0.27 Per Share Dividend

DELRAY BEACH, Fla., May 06, 2019 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the fiscal year ended March 31, 2019.  Net sales for the quarter ended March 31, 2019 were $64.6 million, compared to $67.3 million for the quarter ended March 31, 201…
Show more

PetMed Express Frequently Asked Questions

  • When was PetMed Express founded?

    PetMed Express was founded in 1996.

  • How many employees does PetMed Express have?

    PetMed Express has 199 employees.

  • What is PetMed Express revenue?

    Latest PetMed Express annual revenue is $283.4 m.

  • What is PetMed Express revenue per employee?

    Latest PetMed Express revenue per employee is $1.4 m.

  • Who are PetMed Express competitors?

    Competitors of PetMed Express include HealthWarehouse.com, Medstoreland and Vets First Choice.

  • Where is PetMed Express headquarters?

    PetMed Express headquarters is located at 1441 SW 29th Ave, Pompano Beach.

  • Where are PetMed Express offices?

    PetMed Express has offices in Pompano Beach and Delray Beach.

  • How many offices does PetMed Express have?

    PetMed Express has 3 offices.